Bladder leiomyosarcoma in a patient with chronic ketamine abuse: A case report

9Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Bladder leiomyosarcoma is a rare mesenchymal tumour, accounting for less than 0.5% of all primary bladder malignancies. Adult women of reproductive age have the higher incidence of bladder leiomyosarcoma. Exposure to local pelvic radiotherapy or systemic chemotherapy, especially cyclophosphamide therapy, is also a significant risk factor. We describe a case of a 31-year-old male who developed urinary bladder leiomyosarcoma. The patient had no history of radiotherapy, systemic chemotherapy, or other significant event, except a 5-year history of ketamine abuse. The tumour was found on the left bladder wall and was definitively diagnosed by transurethral resection of the bladder tumour. A partial cystectomy was performed. There are no known reports of urinary bladder leiomyosarcoma associated with chronic ketamine abuse; therefore, we speculate that chronic ketamine abuse may be a factor in the development of this infrequent bladder malignancy.

Cite

CITATION STYLE

APA

Zhong, D., Yu, F., Chen, J., Lin, C., & Luo, H. (2015). Bladder leiomyosarcoma in a patient with chronic ketamine abuse: A case report. Canadian Urological Association Journal, 9(7–8), E514–E516. https://doi.org/10.5489/cuaj.2662

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free